About the Anagen Effluvium Session
Anagen effluvium is a form of hair loss that occurs during the anagen, or growth, phase of the hair cycle. This condition is often triggered by factors such as chemotherapy, radiation therapy, or severe stress, leading to rapid shedding of hair. Unlike telogen effluvium, which affects hair follicles that are resting, anagen effluvium directly impacts active hair follicles, resulting in more pronounced and immediate hair loss. Patients may notice hair thinning or bald patches, particularly on the scalp. Treatment focuses on addressing the underlying cause and may include supportive therapies like scalp cooling to minimize hair loss during chemotherapy. Understanding anagen effluvium is crucial for dermatologists and cosmetologists, as timely intervention can help manage the emotional and aesthetic challenges associated with this condition.
Featured Speakers — Anagen Effluvium 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Anagen Effluvium Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Anagen Effluvium Conference 2027
Present Your Research
Oral and poster slots for original Anagen Effluvium work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Anagen Effluvium research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same program, same certificate.
Join IDC 2027 for the Anagen Effluvium track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Anagen Effluvium Conference 2027 — FAQs
What is the Anagen Effluvium track at IDC 2027?
The Anagen Effluvium track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Anagen Effluvium. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Anagen Effluvium sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Anagen Effluvium are all welcome — whether presenting or attending.
Can I present my research in the Anagen Effluvium track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Anagen Effluvium sessions?
Yes. IDC 2027 is a hybrid conference — attend the Anagen Effluvium track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.

